Kennedy Krieger Institute is a world leader in autism research and clinical care, known for its comprehensive diagnostic evaluations and pioneering studies on ASD prevalence and diagnostic criteria. Their multidisciplinary approach integrates clinical, educational, and research expertise to improve diagnostic accuracy and treatment outcomes.

CADB is recognized for its cutting-edge research on autism diagnosis, neuroimaging, and co-occurring psychiatric conditions. It integrates clinical care with research on diagnostic boundaries and the neurobiological underpinnings of ASD, contributing to improved diagnostic specificity.

Marcus Autism Center is a leader in early diagnosis and intervention research, with a strong emphasis on epidemiology and health services research related to ASD. Their work includes evaluating diagnostic practices and addressing disparities in access to care.

OHSU is notable for its contributions to understanding diagnostic challenges in autism, including the work of Dr. Eric Fombonne, a leading epidemiologist in ASD research. The institution focuses on diagnostic accuracy, co-occurring conditions, and the implications of diagnostic criteria changes.

MUHC, with experts like Dr. Lester Liao, contributes to the discourse on autism diagnosis, particularly regarding diagnostic boundaries and ethical considerations. Their research includes clinical and policy perspectives on ASD diagnosis and resource allocation.